Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

transcreation

Pharma deals during February 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

IQWiG rejects Cell Therapeutics’ Pixuvri

Rules non-Hodgkin lymphoma drug provides 'no additional benefit'

- PMLiVE

Bayer fails to overturn Nexavar compulsory licence in India

Natco Pharma allowed to sell cut-price version of cancer drug

- PMLiVE

AZ loses Crestor patent battle in Australia

Follows challenge from Apotex

- PMLiVE

FDA approves J&J’s Bluetooth blood glucose monitor

Licenses iPhone, iPad and iPod Touch compatible monitoring system

- PMLiVE

Roche gains EU approval for Perjeta in breast cancer

Available in combination with Herceptin and docetaxel chemotherapy

- PMLiVE

Novo’s Lantus rival Tresiba hits European markets

Company says its insulin degludec is a more flexible alternative to Sanofi's product

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales

Joins as company prepares to advance APF350 to treat side effects of chemotherapy

Interview: Steve Bates, BIA

The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces

- PMLiVE

Celgene’s apremilast set for 2013 filing

Pharma company releases positive phase III results for psoriasis candidate

- PMLiVE

Injectables land-grab set to continue as Hikma reports offers

Comes just days after Mylan strikes a major deal to increase its presence in the area

- PMLiVE

Boehringer partners with PatientsLikeMe on rare disease community

Collaborates with the online patient community on idiopathic pulmonary fibrosis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links